Home/ Supplements/ Omega 3/ Fish Oil Multi

Fish Oil Multi

product on market Softgel Capsule Carlson Safety: 99/100
99/100

This product looks safe

  • Folate: 340mg is 340.0× the Tolerable Upper Intake Level (1.0mg)
  • 62% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This product contains Vitamin A, which is supported by strong evidence for maintaining vision and immune function. The remaining profile consists of basic macronutrients that provide foundational energy. Research coverage for this specific ingredient combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Folate: 340mg is 340.0× the Tolerable Upper Intake Level (1.0mg)

Label

Product Label

Label for Fish Oil Multi
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
120
Servings
Other Combinations
Product Type
62%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Total Fat
1 Gram(s) (1% DV)
Total Carbohydrates
1 Gram(s) (1% DV)
Protein
1 Gram(s)
Vitamin A
1500 mcg RAE (167% DV)
Vitamin C
300 mg (333% DV)
20 mcg (100% DV)
1.3× RDA — within safe limits 608 studies (A:16, B:251)
134 mg (893% DV)
8.9× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)
7.5 mg (625% DV)
6.2× RDA — above typical dose 76 studies (A:0, B:33)
8.5 mg (654% DV)
6.5× RDA — above typical dose 13 studies (A:0, B:1)
20 mg (125% DV)
1.4× RDA — within safe limits 196 studies (A:5, B:63)
10 mg (588% DV)
7.7× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
340 mcg DFE (85% DV)
Exceeds UL by 340.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
60 mcg (2500% DV)
25.0× RDA — above typical dose 139 studies (A:1, B:44)
150 mcg (500% DV)
5.0× RDA — above typical dose 27 studies (A:0, B:11)
20 mg (400% DV)
4.0× RDA — above typical dose 2 studies — no high-quality reviews
Calcium
35 mg (3% DV)
150 mcg (100% DV)
Within RDA (1.0× RDA) 245 studies (A:4, B:133)
50 mg (12% DV)
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
7.5 mg (68% DV)
Within RDA (0.7× RDA) 263 studies (A:6, B:134)
105 mcg (191% DV)
1.9× RDA — within safe limits 173 studies (A:0, B:67)
1 mg (111% DV)
1.1× RDA — within safe limits 37 studies (A:0, B:11)
1.5 mg (65% DV)
Within RDA (0.7× RDA) 9 studies — no high-quality reviews
120 mcg (343% DV)
3.4× RDA — above typical dose 199 studies (A:1, B:55)
37.5 mcg (83% DV)
Within RDA (0.8× RDA) 3 studies — no high-quality reviews
400 mcg
Market median: 10.0mg (105 products) 2 studies (A:0, B:1)
1 mg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews
200 mcg
Market median: 0.5mg (6 products) 1 studies (A:0, B:1)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Soft Gel Shell Beeswax Soy Lecithin Rice Flour Soybean Oil Microcrystalline Cellulose Olive Oil Medium Chain Triglyceride Oil
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Adults: take one soft gel daily at mealtime with a full glass of water.

Warnings & Precautions

Contains soy and fish (anchovy, sardine and mackerel).

Formulation Notes

Omega-3s with vitamins & minerals

Heart health Brain function Optimal wellness

A super-strength, iron-free, balanced formula.

Gluten-free No artificial preservatives

An FDA regulated facility

Additional Information

Freshness & potency Purity guaranteed

Metadata

Product Details

UPC / SKU0 88395 01581 6
DSLD Entry Date2021-02-25
Product TypeOther Combinations
FormSoftgel Capsule
BrandCarlson
DSLD ID242125
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.